Alexandre Abreu, MD
Critical Care Medicine · Miami, FLNPI 1497710099
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $20,680 of the $33,919 with a category attached, or 61.0%. Jazz Pharmaceuticals Inc. accounts for 84.1% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $13,190 and has fallen 90.8% since, to $1,216 in 2025. Among critical care medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 210 payments — averaging $161.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$29K
- Harmony Biosciences LLC$2K
- Inspire Medical Systems, Inc.$1K
- Axsome Therapeutics, Inc.$1K
- Resmed Corp$487
- Idorsia Pharmaceuticals US Inc$89
- plus $147 from 3 others
Across 3 payments — averaging $48,336 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Resmed Corp$145K
What the payments were for
- Consulting fees$7002%
- Speaking & faculty fees$20,68061%
- Travel & lodging$5,09815%
- Food & beverage$7,02221%
- Education$4181%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 120 | $28,532 |
| Harmony Biosciences LLC | 41 | $2,146 |
| Inspire Medical Systems, Inc. | 12 | $1,435 |
| Axsome Therapeutics, Inc. | 14 | $1,083 |
| Resmed Corp | 12 | $487 |
| Idorsia Pharmaceuticals US Inc | 5 | $89 |
| Mallinckrodt Hospital Products Inc. | 3 | $72 |
| Fisher & Paykel Healthcare Inc | 1 | $38 |
| Lilly USA, LLC | 2 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$33,919 in reported general payments places this provider in the 95th percentile of 618 critical care medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ramelteon | 15 | $1,503 |
| Zolpidem Tartrate | 101 | $1,235 |
| Ventolin HfaAlbuterol Sulfate | 13 | $717 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $514 |
| Eszopiclone | 12 | $352 |
| Clonazepam | 13 | $197 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in Miami
- Michael CamposMiami$70K
- Daniel KettMiami$14K
- Louis GuzziOrlando$635K
- Fortune AlabiKissimmee$587K
- Debabrata BandyopadhyayTampa$398K
- Fred UmehKissimmee$371K
- Amit TandonWesley Chapel$338K
- Omid ZadOrlando$325K
- Eddy GutierrezJacksonville$315K
- Maximo LamaKissimmee$255K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.